EVR:LSEEvraz PLC Analysis
Data as of 2026-06-19 - not real-time
$371.72
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Evercore (EVR) is trading at $371.72, comfortably above its 20‑day ($350.78), 50‑day ($344.24) and 200‑day ($330.41) moving averages, signaling a strong bullish trend. Technical momentum is reinforced by a bullish MACD histogram (+2.47) and an RSI of 62, indicating upward pressure but still below overbought extremes. Fundamentally, the company boasts an exceptional ROE of 42% and a gross margin above 94%, while its forward PE of 16.2 suggests improving earnings expectations. However, the current PE of 20.9 sits above the industry average of 16.9, hinting at a premium valuation despite a DCF‑derived fair value of $1,027 and a 77% upside potential.
The dividend yield of 0.95% with a modest payout ratio of 19% appears sustainable given robust cash flow and a solid balance sheet (debt‑to‑equity ~53%). Volatility remains high at 36% over 30 days and beta near 1.8, reflecting sensitivity to market swings typical for capital‑markets firms. Recent participation of CEO John S. Weinberg in the Morgan Stanley Financials Conference underscores ongoing strategic visibility, though no material news directly alters the outlook.
Overall, EVR combines strong profitability and cash generation with a technically bullish setup, yet its elevated valuation multiples and high market sensitivity suggest a cautious yet optimistic stance for investors across horizons.
The dividend yield of 0.95% with a modest payout ratio of 19% appears sustainable given robust cash flow and a solid balance sheet (debt‑to‑equity ~53%). Volatility remains high at 36% over 30 days and beta near 1.8, reflecting sensitivity to market swings typical for capital‑markets firms. Recent participation of CEO John S. Weinberg in the Morgan Stanley Financials Conference underscores ongoing strategic visibility, though no material news directly alters the outlook.
Overall, EVR combines strong profitability and cash generation with a technically bullish setup, yet its elevated valuation multiples and high market sensitivity suggest a cautious yet optimistic stance for investors across horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish technical indicators but approaching resistance near $381
- Elevated volatility and beta increase near‑term price swings
- Sustainable dividend provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~77% indicates significant undervaluation
- Strong ROE and operating margins support earnings growth
- Stable cash generation and modest debt levels enhance financial resilience
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- High profitability and consistent dividend payouts suggest durable earnings
- Global investment banking footprint offers long‑term growth avenues
- Robust balance sheet and low payout ratio ensure dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth100.30%
Profit Margin16.40%
P/E Ratio20.9
ROE42.17%
ROA21.35%
Debt/Equity52.59
P/B Ratio8.1
Op. Cash Flow$1.6B
Industry P/E16.9
Technical Analysis
TrendBullish
RSI62.5
Support$330.69
Resistance$381.47
MA 20$350.78
MA 50$344.24
MA 200$330.41
MACDBullish
VolumeStable
Fear & Greed Index92.14
Valuation
Fair Value$1,026.88
Target Price$374.60
Upside/Downside0.77%
GradeUndervalued
TypeBlend
Dividend Yield0.95%
Risk Assessment
Beta1.79
Volatility36.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.